Truist Financial Corporation (TFC) Q3 2026 Earnings Call Transcript
Truist Financial's Q3 2026 earnings miss estimates as securities losses and rising costs weigh on the results despite higher interest income and deposit growth.
Truist Financial NYSE: TFC reported third-quarter 2026 adjusted earnings per share of $1.16, up 12% from a year earlier, as the bank advanced a strategic review aimed at simplifying its business mix, improving balance-sheet composition and redirecting resources toward relationship-based banking businesses.
The headline numbers for Truist Financial (TFC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Truist Financial Corp (NYSE:TFC), the US financial services group, reported adjusted earnings per share of $1.16 for the third quarter, up 12% year on year, despite a $1.4 billion pre-tax loss from repositioning its securities portfolio. Reported diluted earnings per share fell to $0.56 from $1.04 a year earlier, while net income declined to $799 million from $1.45 billion.
Truist Financial Corporation (TFC) came out with quarterly earnings of $1.16 per share, missing the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.04 per share a year ago.
TFC's Q3 earnings are likely to have benefited from loan growth and higher fee income. Rising costs and deteriorating asset quality may have posed challenges.
Truist Financial (TFC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Truist Financial has held its dividend frozen since 2022 while rivals PNC and U.S. Bancorp hand shareholders raises, and the reason why reveals a capital strategy that splits income investors right down the middle.
Truist Financial Corporation enters Q3 2026 earnings with new CEO Michael Lyons, whose strategic direction will be a key focus. Recent $5.5B auto loan sale and exit from less profitable businesses signal ongoing portfolio optimization, with near-term NIM pressure but improved credit quality. Interest rate sensitivity remains contained; TFC's balance sheet is well positioned for gradual rate increases, though macro risks persist.
Truist Financial (TFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
On Tuesday, Sep. 29, uniQure reported four-year AMT-130 data for Huntington's Disease that included cUHDRS & TFC four-year data. cUHDRS at year 4 showed 44% slowing, with a non-significant p=0.144. Per QURE, this may have been due to missing data & “survivor bias” in the external control arm. TFC (total functional capacity) data consistently show >60% slowing of disease progression with statistically significant p-values, albeit nominal ones. TFC is the FDA-aligned confirmatory p3 trial's primary endpoint.